PISCATAWAY, N.J. and SAN DIEGO — GenScript, the world’s leading gene synthesis provider, announced today at the Antibody & Engineering Therapeutics meeting in San Diego the launch of its Precision Mutant Library Services for the drug development, industrial chemical and synthetic biology markets. The service overcomes the challenges of traditional library construction methods, saving researchers valuable screening time, expediting drug discovery and […]
Individual sgRNA and library collections expand Edit-R™ gene editing platform Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation technologies, today announced the addition of predesigned synthetic single guide RNA (sgRNA) to its product range. The sgRNAs, available individually or […]
CARLSBAD, Calif. — Clinical researchers who take a traditional sequential approach to analyze myeloid malignancies, a highly heterogeneous group of disorders, face a major hurdle: a laborious and time-consuming workflow. To simplify and accelerate the genomic profiling process, Thermo Fisher Scientific announced that the Ion Torrent Oncomine Myeloid Research Assay* will be available in 2020 to run […]
Veracyte Acquires Exclusive License to NanoString Diagnostics Platform, Positioning Veracyte To Expand Its Genomic Testing Business Globally Strategic transaction enables Veracyte to access global markets through a world-class, distributed instrument system, with an initial focus on its pulmonology franchise Provides pathway for long-term revenue growth and margin expansion Veracyte to hold conference call and webcast […]
DNAnexus’ FedRAMP-authorized cloud-based platform exemplifies FDA strategy for enhancing the regulatory process through data, technology, and stakeholder engagement. MOUNTAIN VIEW, Calif. – DNAnexus, Inc., the leader in Enterprise Omics Technology, today announced that the U.S. Food and Drug Administration (FDA) has awarded DNAnexus a five-year, $20 million contract to power the precisionFDA Collaborative Omics Environment in the […]
Partnership Expands Physician Access to Clinical Testing that May be Performed in Local Laboratories for Solid Tumor Cancers, Hematological Malignancies and Minimal Residual Disease Monitoring BOULDER, Colo.— ArcherDX, Inc., a growth-stage molecular diagnostics company dedicated to developing breakthrough solutions that advance personalized genomic medicine, today announced a non-exclusive partnership with Illumina, Inc. (NASDAQ: ILMN) to […]
Creates Potential for Significantly Expanded Test Menu Sharpens NanoString’s Strategic Focus on Rapidly Growing Research Business Including Recent Launch of GeoMx Digital Spatial Profiler Strengthens Financial Profile through Capital Infusion and Streamlined Operations SEATTLE – NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to […]
BEIJING–(BUSINESS WIRE)–Genetron Health, a China-based precision oncology company that covers full-cycle cancer care, has obtained regulatory approval in China to launch its GENETRON S5 for clinical use. The approval of a new desktop medium-throughput semiconductor-based next generation sequencing (NGS) system—GENETRON S5, showcases Genetron Health’s ongoing commitment to providing early screening, diagnosis and treatment recommendations, as […]
RIGA, Latvia — MGI officially opened a new R&D and manufacturing facility in Riga, Latvia today, aiming to build a bridge between China and Europe for health science innovation. The new MGI Latvia facility includes a product manufacturing center, high-throughput sequencing center, training center and logistics center. MGI will also establish a China-Europe Life Health […]
DARMSTADT, GERMANY Merck now holds 22 CRISPR-related patents worldwide across nine different geographies Patents cover Paired Cas9 Nickase CRISPR genome-editing technology to advance gene therapy and research Merck, a leading science and technology company, today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
